Thrombocytopenia × Other hematologic neoplasm × Clear all Screening for Hematology Branch Protocols
Enrolling by invitation
10,000 enrolled
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Phase NA Withdrawn
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 Recruiting
9 enrolled
VISCOTHEM-1
Phase NA Completed
48 enrolled
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Active not recruiting
813 enrolled
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Phase 2/3 Completed
21 enrolled 10 charts
Function of Platelets Used for Transfusions
Enrolling by invitation
240 enrolled
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Phase 2 Terminated
21 enrolled
TTRAP-Bleeding
Phase 2 Completed
18 enrolled
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
Phase 2 Completed
23 enrolled 9 charts
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
Phase 1/2 Unknown
181 enrolled
A Rollover Study to Provide Continued Treatment With Eltrombopag
Phase 4 Completed
22 enrolled 9 charts
PROBLEMA
Phase 2 Terminated
29 enrolled 10 charts
MIPLATE
Phase NA Terminated
422 enrolled 24 charts
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
Phase 1/2 Completed
30 enrolled
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Phase 1 Completed
3 enrolled
PrE0901
Phase 1/2 Terminated
15 enrolled 5 charts
Evaluation, Treatment, and Training for Patients With Blood Disorders
Completed
1,452 enrolled
MATTER
Unknown
300 enrolled
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
8 enrolled 6 charts
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
Phase 2 Terminated
4 enrolled 13 charts
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
Phase 2 Completed
148 enrolled 42 charts
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2 Completed
36 enrolled 7 charts
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
Phase 1/2 Completed
25 enrolled 13 charts
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
Phase 2/3 Unknown
220 enrolled
Observational Trial of a Therapeutic Platelet Transfusion Regimen
Terminated
25 enrolled
ASPIRE
Phase 2 Completed
162 enrolled 24 charts
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Phase 2 Completed
30 enrolled
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Phase 3 Unknown
80 enrolled
OPTIMAL
Phase NA Terminated
9 enrolled
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
Phase 1/2 Terminated
4 enrolled
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 1 Completed
39 enrolled
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
Phase 2 Completed
50 enrolled
Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia
Phase 2 Completed
20 enrolled
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
Phase 1/2 Completed
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
Phase 2 Completed
Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
Phase 1 Completed
35 enrolled
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Phase 1/2 Completed
40 enrolled
Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets
Phase 3 Terminated
4 enrolled
Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients
Phase 2 Completed
8 enrolled 3 charts
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
Phase 1 Completed
25 enrolled